4.7 Review

Therapeutic Application of Genome Editing Technologies in Viral Diseases

Journal

Publisher

MDPI
DOI: 10.3390/ijms23105399

Keywords

virus; therapeutics; genome editing; ZFN; TALEN; CRISPR; Cas

Funding

  1. National Research Foundation of Korea (NRF) - Ministry of Science and ICT [2019M3E5D5065771, 2020M3A9C8017745]
  2. National Research Foundation of Korea [2019M3E5D5065771, 2020M3A9C8017745] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Viral infections pose a serious threat to human health and require the development of vaccines and antiviral therapeutic agents. Genome editing technology enables precise modification of genomic sequences and has expanded its applicability in developing therapeutics for viral diseases.
Viral infections can be fatal and consequently, they are a serious threat to human health. Therefore, the development of vaccines and appropriate antiviral therapeutic agents is essential. Depending on the virus, it can cause an acute or a chronic infection. The characteristics of viruses can act as inhibiting factors for the development of appropriate treatment methods. Genome editing technology, including the use of clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated (Cas) proteins, zinc-finger nucleases (ZFNs), and transcription activator-like effector nucleases (TALENs), is a technology that can directly target and modify genomic sequences in almost all eukaryotic cells. The development of this technology has greatly expanded its applicability in life science research and gene therapy development. Research on the use of this technology to develop therapeutics for viral diseases is being conducted for various purposes, such as eliminating latent infections or providing resistance to new infections. In this review, we will look at the current status of the development of viral therapeutic agents using genome editing technology and discuss how this technology can be used as a new treatment approach for viral diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available